Tags

Type your tag names separated by a space and hit enter

Menstrual migraine: clinical and therapeutical aspects.
Expert Rev Neurother. 2007 Sep; 7(9):1105-20.ER

Abstract

Estrogens fluctuations, particularly their premenstrual fall, are currently regarded as the main triggers of menstrual migraine (MM). MM presents in two clinical forms: pure MM, where attacks are confined to the perimenstrual period (PMP), and menstrually related migraine, where attacks always occur during, but are not confined to, the PMP. MM episodes are usually longer, more intense, more disabling and more refractory than nonmenstrual attacks. Acute management of MM should initially be abortive and primarily sought with triptans. If this fails, short-term perimenstrual prophylaxis with NSAIDs, coxibs, triptans or ergotamine derivatives can be considered. Hormone manipulations, mainly application of percutaneous estradiol gel in PMP or administration of oral contraceptives in extended cycles, constitute an alternative approach for nonresponders.

Authors+Show Affiliations

University of Turin, Women's Headache Center, Department of Gynecology & Obstetrics, Via Ventimiglia 3, I-10126 Turin, Italy. gb.allais@tiscali.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

17868010

Citation

Allais, Gianni, et al. "Menstrual Migraine: Clinical and Therapeutical Aspects." Expert Review of Neurotherapeutics, vol. 7, no. 9, 2007, pp. 1105-20.
Allais G, Castagnoli Gabellari I, De Lorenzo C, et al. Menstrual migraine: clinical and therapeutical aspects. Expert Rev Neurother. 2007;7(9):1105-20.
Allais, G., Castagnoli Gabellari, I., De Lorenzo, C., Mana, O., & Benedetto, C. (2007). Menstrual migraine: clinical and therapeutical aspects. Expert Review of Neurotherapeutics, 7(9), 1105-20.
Allais G, et al. Menstrual Migraine: Clinical and Therapeutical Aspects. Expert Rev Neurother. 2007;7(9):1105-20. PubMed PMID: 17868010.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Menstrual migraine: clinical and therapeutical aspects. AU - Allais,Gianni, AU - Castagnoli Gabellari,Ilaria, AU - De Lorenzo,Cristina, AU - Mana,Ornella, AU - Benedetto,Chiara, PY - 2007/9/18/pubmed PY - 2007/10/19/medline PY - 2007/9/18/entrez SP - 1105 EP - 20 JF - Expert review of neurotherapeutics JO - Expert Rev Neurother VL - 7 IS - 9 N2 - Estrogens fluctuations, particularly their premenstrual fall, are currently regarded as the main triggers of menstrual migraine (MM). MM presents in two clinical forms: pure MM, where attacks are confined to the perimenstrual period (PMP), and menstrually related migraine, where attacks always occur during, but are not confined to, the PMP. MM episodes are usually longer, more intense, more disabling and more refractory than nonmenstrual attacks. Acute management of MM should initially be abortive and primarily sought with triptans. If this fails, short-term perimenstrual prophylaxis with NSAIDs, coxibs, triptans or ergotamine derivatives can be considered. Hormone manipulations, mainly application of percutaneous estradiol gel in PMP or administration of oral contraceptives in extended cycles, constitute an alternative approach for nonresponders. SN - 1744-8360 UR - https://www.unboundmedicine.com/medline/citation/17868010/Menstrual_migraine:_clinical_and_therapeutical_aspects_ L2 - https://www.tandfonline.com/doi/full/10.1586/14737175.7.9.1105 DB - PRIME DP - Unbound Medicine ER -